The molecular chaperone HSP60 is a chaperonin homolog of GroEL. We had previously shown that the immunosuppressant mizoribine is bound directly to HSP60 and inhibited its chaperone activity. However, the inhibitory mechanisms of HSP60 by mizoribine have not yet been fully understood. In the present study, we investigated the influence of mizoribine on a folding cycle of HSP60 and co-chaperone HSP10. Our results showed that mizoribine inhibited the folding cycle of HSP60/HSP10. The ATPase activity of HSP60/HSP10 was decreased in the presence of mizoribine and the dissociation of HSP10 from HSP-60 was also decreased by mizoribine. The same functions of GroEL and/or GroES were slightly affected by mizoribine. Based on our findings, we discuss the inhibitory mechanisms of HSP60 by mizoribine.
Braig, K., Otwinowski, Z., Hegde, R., Boisvert, D.C., Joachimiak, A., Horwich, A.L. and Sigler, P.B. (1994) The crystal structure of the bacterial chaperonln GroEL at 2.8 ?. Nature, 371, 578-586. doi:10.1038/371578a0
Lin, Z., Schwartz, F.P. and Eisenstein, E. (1995) The hydrophobic nature of GroEL-Substrate binding. The Journal of Biological Chemistry, 270, 1011-1014. doi:10.1074/jbc.270.3.1011
Xu, Z., Horwich, A.L. and Sigler, P.B. (1997) The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature, 388, 741-750. doi:10.1038/41944
Hartl, F.U. and Hayer-Hartl, M. (2002) Molecular chaperones in the cytosol: From nascent chain to folded protein. Science, 295, 1852-1858. doi:10.1126/science.1068408
Motojima, F., Chaudhry, C., Fenton, W.A., Farr, G.W. and Horwich, A.L. (2004) Substrate polypeptide presents a load on the apical domains of the chaperonin GroEL. Proceedings of the National Academy of Science of the USA, 101, 15005-15012. doi:10.1073/pnas.0406132101
Langer, T., Pfeifer, G., Martin, J., Baumeister, W. and Hartl, F.U. (1992) Chaperonin-Mediated protein folding: GroES binds to one end of the GroEL cylinder, which accommodates the protein substrate within its central cavity. The EMBO Journal, 11, 4757-4765.
Ranson, N.A., Farr, G.W., Roseman, A.M., Gowen, B., Fenton, W.A., Horwich, A.L. and Saibil, H.R. (2001) ATP-bound states of GroEL captured by cryo-electron microscopy. Cell, 107, 869-879. doi:10.1016/S0092-8674(01)00617-1
Kawata, Y., Kawagoe, M., Hongo, K., Miyazaki, T., Higurashi, T., Mizobata, T. and Nagai, J. (1999) Functional communications between the apical and equatorial domains of GroEL through the intermediate domain. Biochemistry, 38, 15731-15740. doi:10.1021/bi9909750
Weissman, J.S., Rye, H.S., Fenton, W.A., Beechem, J.M. and Horwich, A.L. (1996) Characterization of the active intermediate of a GroEL-GroES-mediated protein folding reaction. Cell, 84, 481-490. doi:10.1016/S0092-8674(00)81293-3
Behlke, J., Ristau, O. and Sch?nfeld, H.J. (1997) Nucleotide-dependent complex formation between the Escherichia coli chaperonins GroEL and GroES studied under equilibrium conditions. Biochemistry, 36. 5149-5156. doi:10.1021/bi962755h
Ueno, T., Taguchi, H., Tadakuma, H., Yoshida, M. and Funatsu, T. (2004) GroEL mediates protein folding with a two successive timer mechanism. Molecular Cell, 14, 423-434. doi:10.1016/S1097-2765(04)00261-8
Hartl, F.U. and Hayer-Hartl, M. (2009) Converging concepts of protein folding in vitro and in vivo. Nature Structural and Molecular Biology, 16, 574-581. doi:10.1038/nsmb.1591
Horwich, A.L., Apetri, A.C. and Fenton, W.A. (2009) The GroEL/GroES cis cavity as a passive anti-aggregation device. FEBS Letters, 583, 2654-2662. doi:10.1016/j.febslet.2009.06.049
Guputa, R. S., Venner, T. J. and Chopra, A. (1985) Genetic and biochemical studies with mutants of mammalian cells affected in microtubule-related proteins other than tubulin: Mitochondrial localization of a microtubule-related protein. Canadian Journal of Biochemistry and Cell Biology Revue, 63, 489-502.
Picketts, D.J., Mayanil, C.S.K. and Guputa, R.S. (l989) Molecular cloning of a Chinese hamster mitochondrial protein related to the “chaperonin” family of bacterial and plant proteins. The Journal of Biological Chemistry, 264, 12001-12008.
Singh, B.，Patel, H.V., Ridley, R.G., Freeman, K.B. and Guputa, R.S. (1990) Mitochondrial import of the human chaperonin (HSP60) protein. Biochemical and Biophysical Research Communications, 169, 391-396. doi:10.1016/0006-291X(90)90344-M
Itoh, H., Kobayashi, R., Wakui, H., Komatsuda, A., Ohtani, H., Miura, A.B., Otaka, M., Masamune, O., Andoh, H., Koyama, K., Sato, Y. and Tashima, Y. (1995) Mammalian 60-kDa stress protein (chaperonin homolog). Identification, biochemical properties, and localization. The Journal of Biological Chemistry, 270, 13429-13435. doi:10.1074/jbc.270.22.13429
Nielsen, K.L. and Cowan, N.J. (1998) A single ring is sufficient for productive chaperonin-mediated folding in vivo. Molecular Cell, 2, 93-99. doi:10.1016/S1097-2765(00)80117-3
Levy-Rimler, G., Viitanen, P., Weiss, C., Sharkia, R., Greenberg, A., Niv, A., Lustig, A., Delarea, Y. and Azem, A. (2001) The effect of nucleotides and mitochondrial chaperonin 10 on the structure and chaperone activity of mitochondrial chaperonin 60. European Journal of Biochemistry, 268, 3465-3472. doi:10.1046/j.1432-1327.2001.02243.x
Mizuno, K., Tsujino, M., Takada, M., Hayashi, M. and Atsumi, K. (1974) Studies on Bredinin. I. The Journal of Antibiotics (Tokyo), 27, 775-782. doi:10.7164/antibiotics.27.775
Terai, C., Hakoda, M., Yamanaka, H., Kamatani, N. and Kashiwazaki, S. (1995) Differential cytotoxic effects of mizoribine and its aglycone on human and murine cells and on normal and enzyme-deficient human cells. Biochemical Pharmacology, 50, 1099-1102. doi:10.1016/0006-2952(95)00232-O
Hirohata, S., Nakanishi, K. and Yanagida, T. (2000) Inhibition of cyclin A gene expression in human B cells by an immunosuppressant mizoribine. Clinical and Experimental Immunology, 120, 448-453. doi:10.1046/j.1365-2249.2000.01242.x
Stypinski, D., Obaidi, M., Combs, M., Weber, M., Stewart, A.J. and Ishikawa, H. (2007) Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers. British Journal of Clinical Pharmacology, 63, 459-468. doi:10.1111/j.1365-2125.2006.02779.x
Tanaka, H., Tsugawa, K., Suzuki, K., Nakahata, T. and Ito, E. (2006) Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis. Pediatric Nephrology, 21, 962-966. doi:10.1007/s00467-006-0120-8
Itoh, H., Komatsuda, A., Wakui, H., Miura, A.B. and Tashima, Y. (1999) Mammalian HSP60 is a major target for an immunosuppressant mizoribine. The Journal of Biological Chemistry, 274, 35147-35151. doi:10.1074/jbc.274.49.35147
Motojima, F., Makio, T., Aoki, K., Makino, Y., Kuwajima, K. and Yoshida, M. (2000) Hydrophilic residues at the apical domain of GroEL contribute to GroES binding but attenuate polypeptide binding. Biochemical and Biophysical Research Communications, 267, 842-849. doi:10.1006/bbrc.1999.2020
Agboola, F.K. and Okonji, R.E. (2004). Presence of rhodanese in the cytosolic fraction of the fruit bat (eidolon helvum) liver. Journal of biochemistry and molecular biology, 37, 275-281. doi:10.5483/BMBRep.2004.37.3.275
Machida, K., Fujiwara, R., Tanaka, T., Sakane, I., Hongo, K., Mizobata, T. and Kawata, Y. (2009) Gly192 at hinge 2 site in the chaperonin GroEL plays a pivotal role in the dynamic apical domain movement that leads to GroES binding and efficient encapsulation of substrate proteins. Biochim Biophys Acta, 1794, 1344-1354.
Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A.L. and Hartl, F.U. (1991) Chaperonin-mediated protein folding at the surface of GroEL through a ‘molten globule’-like intermediate. Nature, 352, 36-42. doi:10.1038/352036a0
Koike-Takeshita, A., Yoshida, M. and Taguchi, H. (2008) Revisiting the GroEL-GroES reaction cycle via the symmetric intermediate implied by novel aspects of the GroEL(D398A) mutant. The Journal of Biological Chemistry, 283, 23774-23781. doi:10.1074/jbc.M802542200
Teh, C.E., Daley, S.R., Enders, A. and Goodnow, C.C. (2010) T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency. Proceedings of the National Academy Sciences of the USA, 107, 14709-14714. doi:10.1073/pnas.1009209107
Pfister, G., Stroh, C.M., Perschinka, H., Kind, M., Knoflach, M., Hinterdorfer, P. and Wick, G. (2005) Detection of HSP60 on the membrane surface of stressed human endothelial cells by atomic force and confocal microscopy. Journal of Cell Science, 118, 1587-1594. doi:10.1242/jcs.02292
Pockley, A.G., De Faire, U., Kiessling, R., Lemne, C., Thulin, T. and Frostegard, J. (2002) Circulating heat shock protein and heat shock protein antibody levels in established hypertension. Journal of Hypertension, 20, 1815-1820. doi:10.1097/00004872-200209000-00027
Xiao, Q.Z., Mandal, K., Schett, G., Mayr, M., Wick, G., Oberhollenzer, F., Willeit, J., Kiechl, S. and Xu, Q. (2005) Association of serum-soluble heat shock protein 60 with carotid atherosclerosis. Clinical significance determined in a Follow-up study. Stroke, 36, 2571-2576. doi:10.1161/01.STR.0000189632.98944.ab
Itoh, H., Komatsuda, A., Ohtani, H., Wakui, H., Imai, H., Sawada, K., Otaka, M., Ogura, M., Suzuki, A. and Hamada, F. (2000) Mammalian HSP60 is quickly sorted into the mitochondria under conditions of dehydration. European Journal of Biochemistry, 269, 5931-5938. doi:10.1046/j.1432-1033.2002.03317.x
O’Brien, R.L, Fu, Y.X., Cranfill, R., Dallas, A., Ellis, C., Reardon, C., Lang, J., Carding, S.R., Kubo, R. and Born, W. (1992) Heat shock protein Hsp60-reactive gamma delta cells: A large, diversified T-lymphocyte subset with highly focused specificity. Proceedings of the National Academy Sciences of the USA, 89, 4348-4352. doi:10.1073/pnas.89.10.4348
Wucherpfennig, K.W., Newcombe, J., Li, H., Keddy, C., Cuzner, M.L. and Hafler, D.A. (1992) Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions. Proceedings of the National Academy Sciences of the USA, 89, 4588-4592. doi:10.1073/pnas.89.10.4588
Yifrach, O. and Horovitz, A. (2000) Coupling between protein folding and allostery in the GroE chaperonin system. Proceedings of the National Academy Sciences of the USA, 97, 1521-1524. doi:10.1073/pnas.040449997
Hoshino, M., Kawata, Y. and Goto, Y. (1996) Interaction of GroEL with Conformational States of Horse Cytochrome c. Journal of Molecular Biology, 262, 575-587. doi:10.1006/jmbi.1996.0536
Sameshima, T., Ueno, T., Iizuka, R., Ishii, N., Terada, N., Okabe, K. and Funatsu, T. (2008) Football- and bullet-shaped GroEL-GroES complexes coexist during the reaction cycle. The Journal of Biological Chemistry, 283, 23765-23773. doi:10.1074/jbc.M802541200
Nojima, T. and Yoshida, M. (2009) Probing open conformation of GroEL rings by cross-linking reveals single and double open ring structures of GroEL in ADP and ATP. The Journal of Biological Chemistry, 284, 22834-22839. doi:10.1074/jbc.M109.020057
Kubo, T., Mizobata, T. and Kawata, Y. (1993) Refolding of yeast enolase in the presence of the chaperonin GroE. The nucleotide specificity of GroE and the role of GroES. The Journal of Biological Chemistry, 268, 19346-19351.
Todd, M.J. and Lorimer, G.H. (1995) Stability of the asymmetric Escherichia coli chaperonin complex guanidine chloride causes rapid dissociation. The Journal of Biological Chemistry, 270, 5388-5394. doi:10.1074/jbc.270.10.5388
Aharoni, A. and Horovitz, A. (1996) Inter-ring communication is disrupted in the GroEL mutant Arg13→Gly; Ala126→val with known crystal structure. The Journal of Biological Chemistry, 258, 732-735. doi:10.1006/jmbi.1996.0282
Llorca, O., Pérez-Pérez, J., Carrascosa, J.L., Galán, A., Muga, A. and Valpuesta, J.M. (1997) Effects of the interring communication in GroEL structural and functional. The Journal of Biological Chemistry, 272, 32925-32932. doi:10.1074/jbc.272.52.32925
Miyazaki, T., Yoshimi, T., Furutsu, Y., Hongo, K., Mizobata, T., Kanemori, M. and Kawata, Y. (2002) GroELsubstrate-GroES ternary complexes are an important transient intermediate of the chaperonin cycle. The Journal of Biological Chemistry, 277, 50621-50628. doi:10.1074/jbc.M209183200
Takahashi, S., Wakui, H., Gustafsson, J.-A., Zilliacus, J. and Itoh, H. (2000) Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein. Biochemical and Biophysical Research Communications, 274, 87-92. doi:10.1006/bbrc.2000.3104
Kawasaki, Y. (2009) Mizoribine: A new approach in the treatment of renal disease. Clinical and Developmental Immunology, 2009, Article ID: 681482. doi:10.1155/2009/681482